WO2025008759 - POLYMERIC LEUPROLIDE ACETATE FORMULATIONS
National phase entry:
Publication Number
WO/2025/008759
Publication Date
09.01.2025
International Application No.
PCT/IB2024/056487
International Filing Date
03.07.2024
Title **
[English]
POLYMERIC LEUPROLIDE ACETATE FORMULATIONS
[French]
FORMULATIONS POLYMÈRES D'ACÉTATE DE LEUPROLIDE
Applicants **
TOLMAR INTERNATIONAL LIMITED
Inventors
JANAGAM, Dileep
DUMMER, David
KAUFFMAN, Travis
MIDDLETON, John
VAN HOVE, Amy
MARQUARDT, Nicole
DEWEERD, Nicholas
JOHNSON, Erik Cullen
Priority Data
63/512,016
05.07.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2907 | |
| EPO | Filing, Examination, Granting | 19169 | |
| Japan | Filing, Examination, Granting | 2771 | |
| South Korea | Filing, Examination, Granting | 3208 | |
| USA | Filing, Examination, Granting | 8740 |

Total:
36,795
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Liquid-liquid polymer leuprolide acetate (LA) formulations comprising a biodegradable polymer and biocompatible solvent, and methods of using the formulations.[French]
L'invention concerne des formulations d'acétate de leuprolide (LA) polymère liquide-liquide comprenant un polymère biodégradable et un solvant biocompatible, et des procédés d'utilisation des formulations.